CompletedNot Applicable

Investigation of the Effectiveness of Muscle Inhibition and Space Correction Techniques of Kinesiotaping Method in Female Patients With Myofascial Pain Syndrome Related to Upper Trapezius Active Trigger Points

93 participantsStarted 2013-12

Plain-language summary

To investigate the effectiveness of muscle inhibition and space correction techniques of kinesiotaping (KT) method; on pain, functional status and quality of life in female patients with myofascial pain syndrome (MPS) related to upper trapezius active trigger points (TP) in comparison to control group and to determine the advantage of each technique over another.

Who can participate

Age range

18 Years – 45 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * being female * being aged between 18 and 45 years old * not being in menopausal period * having pain in upper trapezius region * determining a taut band in examination * having at least one active TP in this taut band * the pain produced by palpation of this TP is the pain that the patient complains * painfull restriction of cervical lateral flexion * having pain score 4 or more according to NRS * signing informed consent. Exclusion Criteria: * having major surgery or trauma related to the musculoskeletal system (primarily including the spine and upper extremity) * having any operative history including the head and neck region * having a neuromuscular disease * having an active rheumatic disease * having a systemic disease (diabetes, hypothyroidism, infection, malignancy...) * having any pathology related to musculoskeletal diseases -especially including the cervical region- (cervical discopathy, cervical spondylosis, pathologies related to shoulder joint and surrounding soft tissues, scoliosis, kyphosis, limb length discrepancy, polio sequelae, developmental hip dysplasia...) * having serious psychological problems (having score of 30 or more from Beck Depression Inventory) * being obese (Body Mass Index≥30 kg/m2) * having allergy to kinesiotapes

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in pain related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to first, second and six weeks

Timeframe: Initial assessment, First week, second week, sixth week

Change in disability related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks

Timeframe: Initial assessment, second week, sixth week

Change in quality of life affected by myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks

Timeframe: Initial assessment, second week, sixth week

Trial details

NCT IDNCT03949010

SponsorDilşad Sindel

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-12

View on ClinicalTrials.gov More Female Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP) trials

Plain-language summary

Who can participate

Age range

18 Years – 45 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in pain related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to first, second and six weeks

Timeframe: Initial assessment, First week, second week, sixth week

Change in disability related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks

Timeframe: Initial assessment, second week, sixth week

Change in quality of life affected by myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks

Timeframe: Initial assessment, second week, sixth week